Introduction
Selective kappa opioid receptor (KOPR) ligands with activity in the central nervous system may be useful in the treatment of various disorders, including drug abuse, 1 mood abnormalities, 2,3 and anxiety disorders. 4 Although there are many selective KOPR agonists available for preclinical studies, few selective KOPR antagonists have been identified. The prototypical selective KOPR antagonist norBNI 5 has long been used in preclinical studies. However, recent reports suggest that, in vivo, it may display some mu opioid receptor (MOPR) antagonism in addition to its effects at KOPR. 6, 7 GNTI, 8 and ANTI, 9 two structurally simplified analogues of norBNI, reportedly possess increased selectivity 7 but have not been extensively studied, perhaps due to the complexity of their synthesis and purification. The more recently developed JDTic 10 is a highly potent and selective KOPR antagonist. However, its slow onset (48 h) and long duration (several weeks) of action in vivo can be a limitation for some studies. 11 The development of additional selective KOPR agents, in particular antagonists, will provide alternative tools that enable a better understanding of KOPR mediated effects. Recently, the natural product salvinorin A (1), 12 a high affinity, highly selective agonist at the KOPR, 13 has been used as a lead compound for the design of selective KOPR agonists (full or partial) and antagonists. In vivo, salvinorin A has a fast onset of action and (at least in some tests) a relatively brief duration of effects, [15] [16] [17] probably due to rapid metabolism of its labile acetate. In previous studies, 18, 19 we modified the C-2 substituent and obtained potent and selective KOPR agonists with improved metabolic stability, longer lasting in vivo effects, and oral efficacy. 17 Most early SAR studies focused on the modification of the acetate and methyl ester. 14 Briefly, some small C-2 substituents confer potent KOPR agonism, while bulkier substituents tend to reduce KOPR affinity and in some cases increase MOPR affinity. At C-18, most modifications tested to date substantially reduce binding affinity, suggesting that this part of the molecule binds tightly to a complementary pocket of the KOPR. Only a few modifications ity. 20, 22, 23 In our search for structurally different KOPR antagonists, we were intrigued by reports that some alterations of the furan ring of salvinorin A appeared to confer KOPR antagonist properties.
To further investigate the SAR at this position, we first studied the effect of C-16 substitution. In addition, to assess whether C-12 configuration had any effect on binding, we synthesized 12-episalvinorin A. We subsequently introduced various linkers between C-12 and the furan ring and prepared related C-13 esters, amides, and ketones. Simultaneously, considering the KOPR antagonist properties reported for methyloxadiazole 28a 23 (Scheme 6), we selected it as a lead compound and prepared a set of derivatives containing various 3-substituted oxadiazoles.
Chemistry
We used a modification of the published procedure to prepare 16-bromosalvinorin A (Scheme 1, 2). 22 The reported conditions (NBS in CH 3 CN) formed a complex mixture containing only traces of 2. We found that using CHCl 3 as solvent was more effective, although the yields were highly variable (10-62%). The highest yield was obtained when the reaction was carried out at room temperature overnight using an old bottle of NBS. Addition of AIBN did not affect the progression of the reaction, and absence of light led to the formation of an unknown side product. Stille coupling 24 of 2 and tributylvinyltin in the presence of Pd(PPh 3 ) 4 provided 3 in 58% yield. Bikbulatov et al. recently reported that refluxing 1 in aqueous KOH gave diacid 4 in 69% yield. 25 The structure of 4, featuring inverted configuration at C-12, was firmly established by X-ray crystallography. 25 Interestingly, related diacids have been prepared under the same conditions from diterpenoids lacking the C-1 ketone. 26 The inverted C-12 configuration of 4 raised the possibility of preparing 12-epi-salvinorin A. We prepared 4 in 95% yield using a slight modification of the published procedure (Scheme 2). 25 were without effect on our substrate. However, refluxing AcOH promoted cleavage and lactonization. Subsequent methylation with TMSCHN 2 provided 12-epi-salvinorin A (6). The structure of 6 was established by NMR experiments. The crucial H-10 singlet overlapped with other multiplets in CDCl 3 or (CD 3 ) 2 CO, but a 1:1 mixture of these solvents gave full resolution. The H-8 signal included a diaxial coupling constant (11.7 Hz) , establishing an axial orientation. Irradiation of H-8 gave strong NOE enhancements of both H-10 and H-12, establishing a shared b-configuration. Consistent with this, irradiation of H-12 gave no enhancement of H-20. The proposed structure was firmly established by X-ray crystallography (Fig. 1) . The absolute stereochemistry shown for 6 is taken from that of 1.
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The lactone ring adopts a boat conformation with the furan equatorial. The crystallographic data have been deposited with the Cambridge Crystallographic Data Centre (CCDC 697740).
Replacement of the furan with other substituents at C-12 utilized the acid precursor 7, 22 prepared by the published procedure (Scheme 3). We found that substituting CH 2 Cl 2 for CCl 4 , a potent carcinogen, did not affect the yield. Reduction of 7 using BH 3 ÁTHF 21 afforded alcohol 8 in 46% yield. Methyl and ethyl ethers (9 and 10) were prepared from 8 in the presence of silver oxide, and iodomethane or iodoethane, respectively. Alkylation with 2-iodopropane did not proceed under these conditions. Finally, 8 was acetylated to give 11 in 79% yield. Acid 7 was converted into the unstable acyl chloride using oxalyl chloride in CH 2 Cl 2 (Scheme 4; thionyl chloride was ineffective under the same conditions). The crude product was directly cross-coupled with various aryltributyl tin reagents under Stille conditions 24 to afford C-13 aryl or heteroaryl ketones 12-16 in low to moderate yields. The corresponding ketothiazole derivative decomposed during purification. Subsequently, furan 12 was reduced (NaBH 4 ) to form 17 as a mixture of C-13 epimers in 19% yield. Salvinorins are known to epimerize at C-8 under basic conditions. 28 The possibility that epimerization of 17 had occurred at C-8, rather than the expected C-13, was excluded on the basis of NMR data. The H-12 multiplets were coincident; epimerization at C-8 typically causes a large upfield shift of the H-12 multiplet. The H-20 singlets were nearly coincident (1.35 and 1.37 ppm), and closer to the value for 1 (1.45 ppm) than 8-epi-1 (1.62 ppm). 21 Irradiation of H-12 caused NOE enhancements of H-20 and H-11a, as expected, rather than H-8. Two distinct H-8 multiplets were apparent, both axial as indicated by diaxial coupling constants (11.0 and 11.4 Hz, respectively); the orientation being equatorial in 8-epi-1.
Irradiation of H-8 gave NOE enhancements of H-10 and H-11b. Providing further evidence for epimerization at C-13, the broad H-13 resonances were widely separated (4.89 and 4.60 ppm), and on D 2 O exchange gave doublets with different coupling constants (2.5 and 4.1 Hz). Yields from reduction of other ketones (13) (14) (15) (16) under the same conditions were too low to permit pharmacological evaluation. Inspection of alternative synthetic routes to these secondary alcohols is underway. Analogues with ester and amide groups connected to the C-13 position were readily obtained from 7 as depicted in Scheme 5. Methyl ester 18 was prepared by treatment of 7 with TMSCHN 2 . All other esters 19-22 were synthesized in 26-54% yield using the appropriate alcohol, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), and DMAP. Commercial amines were coupled to 7 in the presence of EDCI and 1-hydroxybenzotriazole (HOBt) to yield amides 23-27. Finally, oxadiazoles 28-34 were obtained in two steps from acid 7 using commercially available amidoximes (Scheme 6). As in previous reports, 23 these conditions led to epimerization at C-8: each epimer was purified by HPLC before in vitro evaluation. 30 The selective KOPR full agonist, U50,488H, was used as a reference compound, with its efficacy designated as 100%. Receptor binding and functional assay data were analyzed using Prism (GraphPad Software Inc., San Diego, CA). K i , EC 50 (potency) and E max (efficacy) values were determined using the same software. The in vitro pharmacological data for those derivatives with detectable KOPR binding affinity (K i < 1000 nM) (1-3, 6-7, 9-11, 13, 16-20) are listed in Table 1 . The dose-response curves of compound 6 and U50,488 in the [ 35 S]GTPcS functional assay are shown in Figure 2 .
In vitro binding and functional assays

Results and discussion
None of the compounds evaluated in this study showed any affinity for the MOPR or DOPR (K i > 1000 nM). 31, 32 Total synthesis allows the preparation of derivatives that may not be achievable by semi-synthetic modification of salvinorin A. In particular, Nozawa et al. 32 suggested that a slight modification of their multi-step synthetic pathway would produce 12-episalvinorin A (6). We used a semi-synthetic approach to prepare 6: cleavage of hemiacetal 4 (Scheme 2) and concomitant lactonization being the key transformations. The binding affinity and potency of 6 at the KOPR (K i = 41 nM, EC 50 = 84 nM) were moderately reduced relative to the natural epimer. Surprisingly, 6 was a partial agonist at KOPR in the [ 35 S]GTPcS assay with 67 ± 5% efficacy relative to U50,488 ( Fig. 2) , a difference of high statistical significance (p < 0.001). In addition, compound 6 partially blocked the effect of U50,488 in the same assay. The next step will e U50,488H values for these assays: K i = 1.6 ± 0.6 nM; EC 50 = 3.2 ± 0.7 nM. be to evaluate if partial agonism and selectivity are maintained in vivo. Inversion at C-12 has surprisingly little effect on the position of the furan ring: superimposition with the crystal structure of 1 (Fig. 3 ) 12 shows that C-13 and the furan oxygen atom are almost coincident in the two structures. That this subtle change in position and orientation should convert a full agonist into a partial one merits further investigation. We then studied the effect of inserting a linker between C-12 and the furan (or other aromatic) rings. No clear SAR patterns were observed for the ketoaryl derivatives 12-16. The fact that the ketothiophene (13) and ketopyrazine (16) analogues display moderate KOPR binding affinity (13: K i = 38 nM, 16: K i = 83 nM), while the other ketones display none is puzzling. The lack of SAR patterns may be due to instability of these arylketones under the assay conditions. Significantly, secondary alcohols 17 (K i = 20 nM) were considerably more potent than the corresponding ketone 12 (K i > 1000 nM). Since 13 and 16 showed enhanced potencies when compared to 12, reduction of their C-13 ketone might lead to even greater potency. An alternative synthetic route to these alcohols is currently being examined.
Alkyl esters (18) (19) (20) demonstrated low KOPR binding affinity (K i = 109-196 nM). Increasing the size of the ester substituent (21, 22) led to complete loss of KOPR affinity. All secondary amides prepared for this study (23) (24) (25) (26) (27) were devoid of KOPR affinity (K i > 1000 nM).
Since a previous report 20 identified methyloxadiazole 28a as a weak KOPR antagonist, we evaluated it along with a few related oxadiazoles (29) (30) (31) (32) (33) (34) 
Conclusions
Our results suggest that it is possible to alter the C-12 substituent of salvinorin A and retain selective KOPR agonism. We developed a four-step synthesis of 12-epi-salvinorin A (6) and found that it induced KOPR partial agonist effects in vitro. Under our conditions, the methyloxadiazole 28a was devoid of antagonist properties as were related oxadiazoles (29) (30) (31) (32) (33) (34) . Further modifications will be necessary to better understand the SAR at this position.
Experimental
General methods
Commercial reagents and solvents were used without further purification. Reactions were monitored by thin-layer chromatography (TLC) using either an ethanolic solution of vanillin and H 2 SO 4 or an aqueous solution of ammonium molybdate, cerium sulfate, and H 2 SO 4 , and heat as developing agents. Products were purified using automated flash chromatography (50 lm silica gel), manual 
Method A
A solution of 7 in oxalyl chloride (2.0 M in CH 2 Cl 2 ) was stirred at room temperature (3 h). The reaction solvent was evaporated and the crude was used immediately without purification for the Stille coupling reaction. The appropriate tributyl tin reagent (1.1 equiv) was added to a mixture of crude acyl chloride and Pd(PPh 3 ) 4 (catalytic amount) in anhydrous toluene and the reaction was stirred at 80-100°C (2-18 h). A saturated aq KF solution and Et 2 O were added to the reaction mixture. The organic layer was dried (MgSO 4 ) and the residue purified by column chromatography to yield the desired product.
Method B
To a solution of 7, EDCI (1.2 equiv), and DMAP (catalytic amount) in CH 2 Cl 2 was added the appropriate alcohol (2.0 equiv). The reaction was stirred at room temperature (3 h). The reaction was washed with an aq 1 M HCl solution, brine, dried (MgSO 4 ), and concentrated in vacuo. The residue was purified by column chromatography to obtain the desired product.
Method C
To a CH 2 Cl 2 solution of 7, EDCI (1.2 equiv), and HOBt (1.2 equiv) was added the appropriate amine (1.5 equiv) and the solution was stirred at room temperature (5-20 min). The reaction was washed with H 2 O, dried (MgSO 4 ), and concentrated in vacuo. The residue was purified by column chromatography (silica gel; CH 2 Cl 2 /CH 3 OH, hexanes/EtOAc, or CH 2 Cl 2 /EtOAc) to obtain the desired product.
Method D
Using a modification of the reported procedure, 23 a mixture of 7, EDCI (1.2 equiv), and HOBt (1.3 equiv) in CH 2 Cl 2 was stirred at room temperature. After 5 min, the appropriate oxime was added and the reaction stirred at room temperature. Upon completion, the reaction was washed with a saturated aq NaHCO 3 solution and brine. The organic layer was dried (MgSO 4 ) and concentrated to give the crude ester. Toluene was added and the solution was refluxed (17-43 h), concentrated, and the crude residue was purified by normal phase HPLC (hexanes/EtOAc).
Vinylfuran 3
Tributylvinyltin (5 lL, 18 lmol) was added to a mixture of 2 (8.4 mg, 16 lmol) and Pd(PPh 3 ) 4 (catalytic amount) in anhydrous toluene (300 lL) and the reaction was stirred at 80°C (18 h). A saturated aq KF solution and Et 2 O were added to the reaction mixture. The organic layer was dried (MgSO 4 ) and the residue purified by column chromatography (silica gel; 0?50% EtOAc/hexanes) to yield 3 (4.4 mg, 58%) as a white powder: R f 0. 32 433.1847.
Alcohol 8
To a THF (3 mL) solution of 7 (157 mg, 382 lmol) was added BH 3 ÁTHF (1.0 M in THF, 0.5 mL, 0.5 mmol) dropwise, and the reaction was stirred at 55°C. After 1 h, the reaction was cooled to room temperature, water (2 mL) was added dropwise and the solution was evaporated. 411.2036.
Ethyl ether 10
To a CH 3 
Thienyl ketone 13
Compound 13 (8.8 mg, 36%) was prepared as a white powder from 7 (21 mg, 51 lmol), oxalyl chloride (1 mL, 2 mmol), Pd(PPh 3 ) 4 (catalytic amount), and 2-(tributylstannyl)thiophene (18 lL, 57 lmol) utilizing method A, stirring the reaction at 100°C (2 h), and using column chromatography (silica gel; 0?33% acetone/hexanes) followed by a second column (silica gel; 0?10% EtOAc/ CH 2 Cl 2 ): R f 0.21 (2:1, hexanes/acetone); 
Furanyl alcohols 17
To a MeOH solution of 12 (82 mg, 178 lmol) was added NaBH 4 (5.8 mg, 153 lmol) and the reaction was stirred at 0°C (1.5 h), concentrated and the residue purified by column chromatography (silica gel; 0?4% MeOH/CH 2 Cl 2 ) followed by a second column (silica gel, 0?40% EtOAc/CH 2 Cl 2 ) and a third column (silica gel, 0?50% EtOAc/hexanes) to yield 17 ( 
